Impact of neoadjuvant chemoradiotherapy on postoperative outcomes after esophageal cancer resection results of a european multicenter study

Annals of Surgery

Volumn 260, Issue 5, 2014, Pages 764-771

  Gronnier, Caroline ^a,b,c   Tréchot, Boris ^a   Duhamel, Alain ^a,d   Mabrut, Jean Yves ^e   Bail, Jean Pierre ^f   Carrere, Nicolas ^g   Lefevre, Jérémie H ^h   Brigand, Cécile ⁱ   Vaillant, Jean Christophe ^j   Adham, Mustapha ^k   Msika, Simon ^l   Demartines, Nicolas ^m   El Nakadi, Issam ⁿ   Piessen, Guillaume ^a,b,c   Meunier, Bernard ^o   Collet, Denis ^p   Mariette, Christophe ^a,b,c,d   Luc, Guillaume ^d   Cabau, Magalie ^d   Jougon, Jacques ^d   Badic, Bogdan ^d   Lozach, Patrick ^d   Cappeliez, Serge ⁿ   Lebreton, Gil ^d   Alves, Arnaud ^d   Flamein, Renaud ^d   Pezet, Denis ^d   Pipitone, Federica ^l   Iuga, Bogdan Stan ^l   Contival, Nicolas ^l   Pappalardo, Eric ^l   Mantziari, Styliani ^m   Hec, Flora ^d   Vanderbeken, Marguerite ^d   Tessier, Williams ^d   Briez, Nicolas ^d   Fredon, Fabien ^d   Gainant, Alain ^d   Mathonnet, Muriel ^d   Bigourdan, Jean Marc ^e   Mezoughi, Salim ^e   Ducerf, Christian ^e   Baulieux, Jacques ^e   Pasquer, Arnaud ^k   Baraket, Oussama ^k   Poncet, Gilles ^k   Vaudoyer, Delphine ^q   Enfer, Peggy Jourdan ^q   Villeneuve, Laurent ^q   Glehen, Olivier ^q   Coste, Thibault ^d   Fabre, Jean Michel ^d   Marchal, Frédéric ^r   Frisoni, Romain ^d   Ayav, Ahmet ^d   Brunaud, Laurent ^d   Bresler, Laurent ^d   Cohen, Charlotte ^d   Aze, Olivier ^d   Venissac, Nicolas ^d   Pop, Daniel ^d   Mouroux, Jérôme ^d   Donici, Ion ^d   Prudhomme, Michel ^d   Felli, Emanuele ^j   Lisunfui, Stéphanie ^j   Seman, Marie ^j   Petit, Gaelle Godiris ^j   Karoui, Mehdi ^j   Tresallet, Christophe ^j   Ménégaux, Fabrice ^j   Hannoun, Laurent ^j   Malgras, Brice ^s   Lantuas, Denis ^s   Pautrat, Karine ^s   Pocard, Marc ^s   Valleur, Patrice ^s   more..

^a LILLE UNIVERSITY HOSPITAL   (France)

^b UNIV LILLE   (France)

^c JEAN PIERRE AUBERT RESEARCH CENTER   (France)

^d SIRIC ^*  (France)

^e CROIX ROUSSE HOSPITAL   (France)

^f BREST UNIVERSITY HOSPITAL   (France)

^g CHU PURPAN   (France)

^h HÔPITAL SAINT ANTOINE   (France)

ⁱ HÔPITAL DE HAUTEPIERRE   (France)

^j PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^k EDOUARD HERRIOT HOSPITAL   (France)

^l HÔPITAL LOUIS MOURIER   (France)

^m LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

ⁿ UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^o PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^p HAUT LÉVÊQUE HOSPITAL   (France)

^q CENTRE HOSPITALIER LYON SUD   (France)

^r Institut de Cancerologie de Lorraine   (France)

^s HÔPITAL LARIBOISIÈRE   (France)

more..

Author keywords

Anastomotic leakage; Chemoradiotherapy; Esophageal cancer; Morbidity; Mortality; Surgery

Indexed keywords

ANTINEOPLASTIC METAL COMPLEX; FLUOROURACIL;

ADJUVANT CHEMORADIOTHERAPY; ADULT; AGED; ANASTOMOSIS LEAKAGE; CANCER STAGING; CARDIOVASCULAR DISEASE; CHYLOTHORAX; CONFERENCE PAPER; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HUMAN; HUMAN TISSUE; LENGTH OF STAY; LUNG DISEASE; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MORBIDITY; MULTICENTER STUDY (TOPIC); OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REOPERATION; RETROSPECTIVE STUDY; SEPSIS; SEX DIFFERENCE; SURGICAL MORTALITY; THROMBOEMBOLISM; ADENOCARCINOMA; ADJUVANT THERAPY; ANASTOMOTIC LEAK; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; CLINICAL TRIAL; COMPARATIVE STUDY; DIAGNOSTIC IMAGING; ESOPHAGEAL NEOPLASMS; EUROPE; LYMPH NODE METASTASIS; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; POSTOPERATIVE COMPLICATIONS; PROPENSITY SCORE; RISK FACTOR; TREATMENT OUTCOME; VERY ELDERLY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANASTOMOTIC LEAK; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; DIAGNOSTIC IMAGING; ESOPHAGEAL NEOPLASMS; EUROPE; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; POSTOPERATIVE COMPLICATIONS; PROPENSITY SCORE; RISK FACTORS; TREATMENT OUTCOME;

EID: 84926118431     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000000955     Document Type: Conference Paper

References (32)

1. Martin LW, Swisher SG, Hofstetter W, et al. Intrathoracic leaks following esophagectomy are no longer associated with increased mortality. Ann Surg. 2005;242:392-402.
2. Crestanello JA, Deschamps C, Cassivi SD, et al. Selective management of intrathoracic anastomotic leak after esophagectomy. J Thorac Cardiovas Surg. 2005;129:254-260.
3. Fernandez FG, Meyers BF. Quality of life after esophagectomy. Semin Thorac Cardiovasc Surg. 2004;16:152-159.
4. Blencowe NS, Strong S, McNair AG, et al. Reporting of short-term clinical outcomes after esophagectomy: A systematic review. Ann Surg. 2012;255: 658-666.
5. Wilke TJ, Bhirud AR, Lin C. A review of the impact of preoperative chemoradiotherapy on outcome and postoperative complications in esophageal cancer patients. Am J Clin Oncol. December 17, 2013 [Epub ahead of print].
6. Ferri LE, Law S, Wong KH, et al. The influence of technical complications on postoperative outcome and survival after esophagectomy. Ann Surg Oncol. 2006;13:557-564.
7. Sauvanet A, Mariette C, Thomas P, et al. Mortality and morbidity after resection for adenocarcinoma of the gastroesophageal junction: predictive factors. J Am Coll Surg. 2005;201:253-262.
8. Wright CD, Kucharczuk JC, O'Brien SM, et al. Predictors of major morbidity andmortality after esophagectomy for esophageal cancer: A Society of ThoracicSurgeons General Thoracic Surgery Database risk adjustment model. J Thorac Cardiovasc Surg. 2009;137:587-595.
9. Kassis ES, Kosinski AS, Ross P, Jr, et al. Predictors of anastomotic leak after esophagectomy: An analysis of the society of thoracic surgeons general thoracic database. Ann Thorac Surg. 2013;96:1919-1926.
10. Mariette C, Piessen G, Briez N, et al. Oesophagogastric junction adenocarcinoma: Which therapeutic approach? Lancet Oncol. 2011;12:296-305.
11. Van Hagen P, Hulshof MC, van Lanschot JJ, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366:2074-2084.
12. Ruol A, Portale G, Castoro C, et al. Effects of neoadjuvant therapy on perioperative morbidity in elderly patients undergoing esophagectomy for esophageal cancer. Ann Surg Oncol. 2007;14:3243-3250.
13. Merritt RE, Whyte RI, D'Arcy NT, et al. Morbidity and mortality after esophagectomy following neoadjuvant chemoradiation. Ann Thorac Surg. 2011;92:2034-2040.
14. Bosch DJ, Muijs CT, Mul VE, et al. Impact of neoadjuvant chemoradiotherapy on postoperative course after curative-intent transthoracic esophagectomy in esophageal cancer patients. Ann Surg Oncol. 2014;21:605-611.
15. Markar SR, Bodnar A, Rosales J, et al. The impact of neoadjuvant chemoradiotherapy on perioperative outcomes, tumor pathology, and survival in clinical stage II and III esophageal cancer. Ann Surg Oncol. 2013;20:3935-3941.
16. Tepper J, Krasna MJ, Niedzwiecki D, et al. Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol. 2008;26:1086-1092.
17. Burmeister BH, Smithers BM, Gebski V, et al. Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: A randomised controlled phase III trial. Lancet Oncol. 2005;6:659-668.
18. Walsh TN, Noonan N, Hollywood D, et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med. 1996;335: 462-467.
19. Mariette C, Dahan L, Mornex F, et al. Surgery alone versus chemoradiation followed by surgery for stage I and II esophageal cancer: final analysis of a randomized controlled phase III trial FFCD 9901. J Clin Oncol. 2014;23: 2416-2422.
20. Piessen G, Messager M, Mirabel X, et al. Is there a role for surgery for patients with a complete clinical response after chemoradiation for esophageal cancer? An intention-to-treat case-control study. Ann Surg. 2013;258: 793-799.
21. Mariette C, Piessen G, Briez N, et al. The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent. Ann Surg. 2008;247:365-371.
22. Sobin LH, Gospodarowicz MK, Wittekind C, eds. UICC TNM Classification of Malignant Tumors. 7th ed. New York, NY: Wiley-Blackwell; 2009.
23. Briez N, Piessen G, Bonnetain F, et al. Open versus laparoscopically-assisted oesophagectomy for cancer: A multicentre randomised controlled phase III trial-the MIRO trial. BMC Cancer. 2011;11:310.
24. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205-213.
25. Reynolds JV, Ravi N, Hollywood D, et al. Neoadjuvant chemoradiation may increase the risk of respiratory complications and sepsis after transthoracic esophagectomy. J Thorac Cardiovasc Surg. 2006;132:549-555.
26. Courrech Staal EF, Aleman BM, Boot H, et al. Systematic reviewof the benefits and risks of neoadjuvant chemoradiation for oesophageal cancer. Br J Surg. 2010;97:1482-1496.
27. Adenis A, Mirabel X, Mariette C. Is preoperative chemoradiation with paclitaxel and carboplatin a new standard of treatment for esophageal cancer? Int J Radiat Oncol Biol Phys. 2013;86:16-17.
28. Byrne M, Reynolds JV, O'Donnell JS, et al. Long-term activation of the pro-coagulant response after neoadjuvant chemoradiation and major cancer surgery. Br J Cancer. 2010;102:73-79.
29. Starling N, Rao S, Cunningham D, et al. Thromboembolism in patients with advanced gastroesophageal cancer treated with anthracycline, platinum, and fluoropyrimidine combination chemotherapy: A report from the UK National Cancer Research Institute Upper Gastrointestinal Clinical Studies Group. J Clin Oncol. 2009;27:3786-3793.
30. Seng S, Liu Z, Chiu SK, et al. Risk of venous thromboembolism in patients with cancer treated with Cisplatin: A systematic review and meta-analysis. J Clin Oncol. 2012;30:4416-4426.
31. Kranzfelder M, Gertler R, Hapfelmeier A, et al. Chylothorax after esophagectomy for cancer: impact of the surgical approach and neoadjuvant treatment: Systematic review and institutional analysis. Surg Endosc. 2013;27:3530- 3538.
32. Lonjon G, Boutron I, Trinquart L, et al. Comparison of treatment effect estimates from prospective nonrandomized studies with propensity score analysis and randomized controlled trials of surgical procedures. Ann Surg. 2014:259:18-25.